Nexus Pharmaceuticals recalls

FDA enforcement reports naming Nexus Pharmaceuticals Inc as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Sep 4, 2013

Severity

Sep 4, 2013Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only…Drug · Nexus Pharmaceuticals IncPresence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.Class II